Skip to main content
. 2023 Apr 7;142(6):509–518. doi: 10.1182/blood.2022018071

Figure 1.

Figure 1.

Hematopoietic stem cell markers and their potential signaling interactions governing their biology. A schematic diagram of potential signaling pathways downstream of key markers expressed on CD34+(CD38/CD45RA)EPCR+ HSCs (which are also CD49f+ and CD90+/) upon interacting with their potential ligands in the niche. This highly HSC-enriched population highly expresses CD33, CD93, CD117, CD133, and CD143.30 We hypothesize that these cells may also express GPRC5C and CD370 as well as PAR1 and ATR1 (to convey the EPCR/APC/PAR1 and CD143/Ang-/ATR1 signaling, respectively).